Skip to main content
AMRX
NASDAQ Life Sciences

BRIEF-Amneal Pharmaceuticals Q4 Revenue USD 814.319 Million Vs. IBES Estimate USD 807.9 Million

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$14.49
Mkt Cap
$4.555B
52W Low
$6.685
52W High
$15.42
52W Position info
117% above low
Off High info
6.0% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $6.685.

Summary

Amneal Pharmaceuticals reported Q4 revenue of $814.319 million, exceeding the IBES estimate of $807.9 million. The company also issued its full-year guidance, forecasting revenue between $3,050 million and $3,150 million, adjusted EBITDA of $720 million to $760 million, and operating cash flow of $325 million to $375 million. This revenue beat signals a stronger-than-anticipated quarterly performance. The comprehensive full-year outlook provides crucial forward-looking data that will significantly impact analyst models and investor sentiment regarding the company's future financial trajectory.

At the time of this announcement, AMRX was trading at $14.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $6.69 to $15.42. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 17, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.12
Real-time Price: $21.78 info
Change: +$0.6646 (+3%) info
Market Cap: $7.358B info
AMRX
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.28
Real-time Price: $21.78 info
Change: +$0.5046 (+2%) info
Market Cap: $7.358B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $21.78 info
Change: +$1.56 (+8%) info
Market Cap: $7.358B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $21.78 info
Change: +$1.58 (+8%) info
Market Cap: $7.358B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $21.78 info
Change: +$1.40 (+7%) info
Market Cap: $7.358B info